Mary Beth Harler - 02 Oct 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Executive Officer, Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
02 Oct 2024
Net transactions value
$0
Form type
4
Filing time
04 Oct 2024, 18:23:34 UTC
Previous filing
17 Sep 2024
Next filing
18 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +185,000 +113% $0.000000 348,740 02 Oct 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Stock Option (right to buy) Award $0 +370,000 $0.000000 370,000 02 Oct 2024 Common Stock 370,000 $14.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-third of the RSUs shall vest on November 12, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
F2 1/48th of the shares subject to the option shall vest on October 30, 2024 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.